Skip to Main Content

Paper Details

KTE-X19 anti-CD19 CAR T-cell therapy in adult relapsed/refractory acute lymphoblastic leukemia: ZUMA-3 phase 1 results.
Blood
88
2021
Author NameAffiliation
Bijal ShahMoffitt Cancer Center
Daniel J DeAngeloDana-Farber Cancer Institute
John T SchillerDavid Geffen School of Medicine, University of California at Los Angeles
  • 1 - 3

Datasets

Release 1.2